Sodium-glucose cotransporter 2 inhibitors (SGLT2i), a recent development in diabetes treatment, show promise beyond controlling blood sugar levels in type 2 diabetes patients.
Recent studies reveal their potential to offer additional health benefits, especially compared to older diabetes drugs like dipeptidyl peptidase-4 inhibitors (DPP4i).
Kidney and Respiratory Protection
Researchers from the University of Hong Kong delved into the health impacts of SGLT2 inhibitors on over 30,000 type 2 diabetes patients.
Their findings were enlightening. SGLT2 inhibitors not only showed a strong connection to reduced risks of severe kidney diseases, including end-stage renal disease (ESRD), but also demonstrated protective effects against respiratory issues such as obstructive airway disease (OAD) and pneumonia.
These findings are groundbreaking, as previous studies primarily focused on the cardiovascular and renal benefits of SGLT2 inhibitors.
While the study suggests SGLT2 inhibitors as a superior alternative to DPP4 inhibitors, it’s crucial to consider potential side effects. SGLT2 inhibitors can increase the risk of genital and urinary tract infections and diabetic ketoacidosis.
Therefore, it’s important for patients to have a thorough discussion with healthcare providers about the benefits and risks of these medications.
A Comprehensive Treatment Approach
This research from the University of Hong Kong underlines the importance of evaluating all treatment options for type 2 diabetes.
SGLT2 inhibitors, with their added cardiorenal and respiratory protective effects, present a promising choice for patients. However, further research is essential to understand how these drugs offer such broad protective benefits.
As the medical community continues to explore these avenues, patients with type 2 diabetes might find more comprehensive and effective treatment strategies emerging.
For individuals concerned about diabetes, it’s advisable to stay informed about the latest research developments and discuss with healthcare professionals to choose the most suitable treatment plan.
If you care about diabetes, please read studies that not all whole grain foods could benefit people with type 2 diabetes, and green tea could help reduce death risk in type 2 diabetes.
For more nutrition information, please see recent studies about unhealthy plant-based diets linked to metabolic syndrome and results showing Mediterranean diet could help reduce the diabetes risk by one-third.
Copyright © 2023 Knowridge Science Report. All rights reserved.
